: Schematic representation of the AdRGD-PG vectors. ITR: adenoviral replicative inverted terminal repeats; attR1 and attR2: site-specific recombination sequences; PG/Tx/βglob: p53-responsive promoter, composed by PG enhancer sequence, TATA box (Tx) and βglobin (βglob) intronic sequences;; eGFP: enhanced green fluorescent protein cDNA sequence; p19Arf: p19Arf cDNA sequence; IFNβ: mouse interferon-β cDNA sequence; IRES: internal ribosome entry site sequence; PA: polyadenylation sequence; V5 epitope: V5 epitope of adenoviral capsid sequence; ΔE1/E3: deletion of genes E1 and E3. Cells were transduced with AdRGD-PG vectors and incubated for 36 hours before total RNA extraction and RT-qPCR analysis of p53 pathway genes (Trp53, p21Waf1 (Cdkn1a), PUMA, PHLDA3). β-Actin and/or glyceraldehyde 3-phosphate dehydrogenase (GAPDH) were used as the reference genes. Data represents the average and s.d. from duplicated PCR reactions derived from 5 independent biological experiments. *P<0.05, **P<0.01 one-way analysis of variance, followed by Kruskal-Wallis.
